Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Adrian Gerard Murphy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-9983-8641; OpenAlex author ID A5021680577. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
64
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in adv… Co-author DOI 10.1186/s12885-025-14512-2↗
  2. Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017. Co-author DOI 10.1016/j.canlet.2020.10.039↗
  3. A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. Co-author DOI 10.1111/cts.12802↗
  4. Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/apc.2020.03.03↗
  5. IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma. Co-author DOI 10.1172/jci124077↗
  6. Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. Co-author DOI 10.1002/cam4.1104↗
  7. Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. Co-author DOI 10.18632/oncotarget.22433↗
  8. Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation. Co-author DOI 10.1158/0008-5472.can-15-3264↗

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Zheng · 6 shared papers, 2016–2021 · strength 0.50
  2. Stephen T. Muth · 2 shared papers, 2019–2020 · strength 0.25
  3. David J. Easty · 1 shared paper, 2026 · strength 0.23
  4. Derek Gerard Power · 1 shared paper, 2026 · strength 0.23
  5. Patrick Glyn Morris · 1 shared paper, 2026 · strength 0.23
  6. Bryan T. Hennessy · 1 shared paper, 2026 · strength 0.23
  7. Ray McDermott · 1 shared paper, 2026 · strength 0.23
  8. Alex B. Blair · 3 shared papers, 2017–2021 · strength 0.23
  9. Nilofer Saba Azad · 3 shared papers, 2017–2021 · strength 0.22
  10. Elizabeth M. Jaffee · 3 shared papers, 2016–2021 · strength 0.20
  11. Victoria M. Kim · 2 shared papers, 2017–2019 · strength 0.15
  12. Mengni He · 1 shared paper, 2020 · strength 0.15
  13. Robert A. Anders · 2 shared papers, 2016–2021 · strength 0.13
  14. Christopher L. Wolfgang · 2 shared papers, 2016–2021 · strength 0.13
  15. Agnieszka A. Rucki · 2 shared papers, 2016–2017 · strength 0.13
  16. Dung Thi Le · 2 shared papers, 2017–2021 · strength 0.12
  17. Jin Peng He · 2 shared papers, 2017–2021 · strength 0.12
  18. Ana De Jesus-Acosta · 2 shared papers, 2017–2021 · strength 0.12
  19. Amy Hacker-Prietz · 2 shared papers, 2017–2021 · strength 0.12
  20. Valerie Lee · 2 shared papers, 2017–2021 · strength 0.12
  21. Ross C. Donehower · 2 shared papers, 2017–2021 · strength 0.12
  22. Matthew John Weiss · 2 shared papers, 2017–2021 · strength 0.12
  23. Amol Kumar Narang · 2 shared papers, 2017–2021 · strength 0.12
  24. Elliot K. Fishman · 2 shared papers, 2017–2021 · strength 0.12
  25. Ralph H. Hruban MD · 2 shared papers, 2017–2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.